GEFCO Group has been awarded Good Distribution Practice (GDP) compliance certification by Bureau Veritas for transporting pharmaceuticals across its road network.
The certificate, which is valid for three years, demonstrates GEFCO’s fulfilment of the European Commission Guidelines on GDP of Pharmaceutical Products for human use, and reflects the company’s quality of service as well as understanding clients’ challenges including the traceability of goods to reduce the risk of counterfeit or falsification.
The external auditor assessed GEFCO’s quality system and its ability to answer customer requirements in the Czech Republic, Slovakia, Hungary, Greece, Romania and the Group’s headquarters in France.
GEFCO head of management system, Alain Vignon says: “GEFCO has a strong history in the Life Science and Healthcare sector and is fully aware of its clients’ stakes. The GDP compliance is further proof of GEFCO’s commitment to supplying secure and compliant Life Sciences and Healthcare shipments and ensuring the integrity of all products.”
The company offers door-to-door, temperature-controlled, integrated logistics, multimodal and fully compliant solutions for the life science and healthcare logistics industry, and in 2019 GEFCO will extend the GDP certification for road activities to other European countries.
Earlier this year GEFCO opened its third Life Sciences and Healthcare dedicated temperature-controlled warehouse near Heathrow Airport, complimenting its Air & Sea warehouses in Frankfurt, Germany and Amsterdam, the Netherlands.
Last year the group was also awarded IATA CEIV Pharma certification for its Air & Sea warehouse in Amsterdam.